m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00127)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
MIR25
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | Cigarette smoke-induced microRNA 25 (MIR25) excessive maturation via m6A modification promotes the development and progression of pancreatic cancer. This modification is catalyzed by overexpressed methyltransferase-like 3 (METTL3) due to hypomethylation of the METTL3 promoter also caused by CSC. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Pancreatic cancer | ICD-11: 2C10 | ||
Pathway Response | PI3K-Akt signaling pathway | hsa04151 | ||
Cell Process | Cell proliferation | |||
In-vitro Model | HEK293T | Normal | Homo sapiens | CVCL_0063 |
BxPC-3 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0186 | |
HPDE6c7 | Normal | Homo sapiens | CVCL_0P38 | |
PANC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0480 | |
SW1990 | Pancreatic adenocarcinoma | Homo sapiens | CVCL_1723 | |
In-vivo Model | Mice (five in each group) were injected subcutaneously with 0.1 ml of cell suspension containing 2 × 106 cells in the back flank. | |||
Pancreatic cancer [ICD-11: 2C10]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | Cigarette smoke-induced microRNA 25 (MIR25) excessive maturation via m6A modification promotes the development and progression of pancreatic cancer. This modification is catalyzed by overexpressed methyltransferase-like 3 (METTL3) due to hypomethylation of the METTL3 promoter also caused by CSC. | |||
Responsed Disease | Pancreatic cancer [ICD-11: 2C10] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
Pathway Response | PI3K-Akt signaling pathway | hsa04151 | ||
Cell Process | Cell proliferation | |||
In-vitro Model | HEK293T | Normal | Homo sapiens | CVCL_0063 |
BxPC-3 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0186 | |
HPDE6c7 | Normal | Homo sapiens | CVCL_0P38 | |
PANC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0480 | |
SW1990 | Pancreatic adenocarcinoma | Homo sapiens | CVCL_1723 | |
In-vivo Model | Mice (five in each group) were injected subcutaneously with 0.1 ml of cell suspension containing 2 × 106 cells in the back flank. | |||